Developer docs
API playgroundTry for free, no card

Search company profiles

Velano Vascular

Full company profile

uuid0002dy9

Namestring
Velano Vascular
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Velano Vascular is a San Francisco-based medical device company founded in 2012 that developed the PIVO™ needle-free blood collection platform, a proprietary technology that advances a flexible internal flow tube through existing peripheral IV catheters (PIVCs) to enable high-quality blood draws without additional venipuncture. The technology targets the inpatient hospital setting, where the standard of care requires repeated needle sticks for diagnostic blood collection, and addresses pain, vessel damage, preanalytical specimen errors, and needlestick injury exposure. Velano's commercial portfolio, now sold by Becton, Dickinson and Company following an acquisition, includes the PIVO™ Pro Needle-Free Blood Collection Device (20G and 22G-compatible SKUs), the Nexiva™ Closed IV Catheter System with NearPort™ IV Access, and the ExT™ Stabilized Extension Set, sold together as the BD Peripheral Line Draw Solution.

The company monetized through unit-priced hardware sales to hospital systems and integrated delivery networks via direct enterprise sales, GPO contracting, and value analysis committee engagement. Pricing was negotiated at the system level and not publicly disclosed. Velano accumulated approximately $71.2M in disclosed equity funding across eight rounds from 2013 through 2019, with strategic participation from hospital systems including Intermountain Healthcare, Sutter Health, Griffin Hospital, and The Children's Hospital of Philadelphia. The company built an extensive clinical evidence base, including multi-center studies across 23 hospitals demonstrating 56% reduction in preanalytical errors and 19% reduction in IV replacement rates, a 7,600-draw retrospective review showing 39% lower hemolysis versus venipuncture, and infection-prevention evidence documenting 31.9%-41.8% reduction in hospital-onset bacteremia and fungemia rates.

Post-acquisition by BD, PIVO is sold as part of BD's broader vascular access and medication delivery portfolio through BD's global direct sales force, GPO contracts, customer portals, and the BD Learning Academy training platform. Velano Vascular itself no longer operates as an independent entity; its technology, SKUs, clinical evidence, and customer relationships have been absorbed into BD's enterprise.

Short descriptiontext

Velano Vascular developed the PIVO™ needle-free blood collection platform, which advances a flexible tube through existing peripheral IV catheters to enable inpatient blood draws without additional venipuncture. The San Francisco-based medical device company, founded in 2012 and acquired by BD, served hospital systems and integrated delivery networks.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
needle-free blood collection, vascular access devices, peripheral IV catheters, medical device innovation, blood draw technology
Industry2 codes
PRIMARYHLAHAKAE
Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories)
SECONDARYHLAHAIAD
Needle-Free Injection Systems (Jet Injectors/Microneedle Patches)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Vascular Access / Needle-Free Blood Collection Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales — PIVO™ Pro and Compatible IV Catheter Systems
TypeHardware Sales
Description

Sale of PIVO™ Pro Needle-Free Blood Collection Devices, Nexiva™ Closed IV Catheter Systems, and ExT™ Stabilized Extension Sets to hospital systems and healthcare providers. Revenue is generated through direct hospital procurement and distribution channels, with devices ordered via standard hospital supply chain and GPO contracting processes. Pricing is typically negotiated at system level through value analysis committees.

bd.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Pricing details4 tiers
1PIVO™ Pro Needle-Free Blood Collection Device — 20G compatible
ModelUnit PricingBilling cadencePay-as-you-go
Notes

SKU/REF 393657; pricing not publicly disclosed

bd.com
2PIVO™ Pro Needle-Free Blood Collection Device — 22G compatible
ModelUnit PricingBilling cadencePay-as-you-go
Notes

SKU/REF 393653; pricing not publicly disclosed

bd.com
3Nexiva™ Closed IV Catheter System with NearPort™ IV Access — multiple gauge/length configurations
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Multiple SKUs: 393530 (18G x 1.75in), 393529 (18G x 1.25in), 393528 (20G x 1.75in), 393527 (20G x 1.25in), 393526 (20G x 1.00in), 393523 (22G x 1.75in), 393522 (22G x 1.00in), 393521 (24G x 0.75in); pricing not publicly disclosed

bd.com
4ExT™ Stabilized Extension Set with NearPort™ IV Access — with and without MaxZero™ Connector
ModelUnit PricingBilling cadencePay-as-you-go
Notes

SKU/REF 390221 (with MaxZero connector), 390220 (without); pricing not publicly disclosed

bd.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Velano Vascular developed the PIVO needle-free blood collection platform, a proprietary medical device system that enables high-quality blood draws from existing peripheral IV catheters without additional venipuncture. The portfolio includes the PIVO Pro Needle-Free Blood Collection Device (20G and 22G configurations), the Nexiva Closed IV Catheter System with NearPort IV Access, and ExT Stabilized Extension Sets with optional MaxZero needle-free connectors, sold as the BD Peripheral Line Draw Solution to hospital systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 56% decrease in pre-analytical errors
+9 more records
Product overview1 text field

Velano Vascular (now part of BD) offers the PIVO™ Pro Needle-Free Blood Collection Device, a medical device that enables needle-free blood draws from existing peripheral IV catheters. The product portfolio includes PIVO™ Pro devices in multiple gauge sizes (20G, 22G) and complementary products including the Nexiva™ Closed IV Catheter System with NearPort™ IV Access and ExT™ Stabilized Extension Sets. These products work together as the BD Peripheral Line Draw Solution, designed to reduce needlesticks, improve patient experience, decrease preanalytical errors, and minimize IV catheter replacements. The solution integrates with BD's broader portfolio of blood collection products including BD Vacutainer® Luer-Lok™ Access Device and BD Vacutainer® Blood Collection Tubes.

Product and service5 records
1PIVO Pro Needle-Free Blood Collection Device (20G compatible)
CategoryNeedle-Free Blood Collection Devices
Description

A needle-free blood collection device compatible with 20G IVs that advances a flexible internal flow tube through existing peripheral IV catheters to access optimal draw conditions beyond the catheter tip, enabling high-quality blood draws without additional venipuncture. Targeted at hospital systems, vascular access teams, and phlebotomy services.

2PIVO Pro Needle-Free Blood Collection Device (22G compatible)
CategoryNeedle-Free Blood Collection Devices
Description

A needle-free blood collection device compatible with 22G IVs or larger, designed to achieve high-quality blood draws from existing peripheral IV catheter lines without additional venipuncture. Targeted at hospital inpatient settings and patients requiring frequent blood sampling.

3Nexiva Closed IV Catheter System with NearPort IV Access
CategoryPeripheral IV Catheter Systems
Description

A closed IV catheter system with NearPort IV Access designed to improve peripheral IV catheter dwell times and reduce complications, compatible with the PIVO Pro needle-free blood collection device for integrated vascular access workflows. Targeted at hospital systems and vascular access teams.

4ExT Stabilized Extension Set with NearPort IV Access (without MaxZero Connector)
CategoryVascular Access Accessories
Description

A stabilized extension set with NearPort IV Access enabling the PIVO Pro needle-free blood collection device to be used with traditional short peripheral IV catheters in hospital workflows. Targeted at hospitals using non-integrated catheter systems that want to adopt needle-free blood collection.

5ExT Stabilized Extension Set with NearPort IV Access and MaxZero Needle-free Connector
CategoryVascular Access Accessories
Description

A stabilized extension set with NearPort IV Access and an integrated MaxZero needle-free connector providing a closed-system blood draw workflow with PIVO Pro compatibility for traditional short IV catheters. Targeted at hospitals seeking enhanced safety and closed-system compatibility for needle-free blood collection.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor in IV catheters, needle-free connectors, and closed vascular access systems. ICU Medical's acquisition of Smiths Medical expanded its peripheral IV catheter and blood sampling portfolio, putting it in direct competition with the PIVO/Nexiva platform for hospital value-analysis wins.

2Medline Industries
TypeBroad incumbent
Description

Large private manufacturer and distributor of medical supplies with an IV therapy and vascular access portfolio. Medline competes for GPO/IDN vascular access and phlebotomy contracts at hospitals considering PIVO adoption.

TypeDirect peer
Description

Global manufacturer of IV catheters, needle-free connectors, and infusion therapy disposables. B. Braun competes directly with PIVO/Nexiva for inpatient vascular access standardizations and blood draw workflow improvements in hospital systems.

TypeEmerging player
Description

Specialty needle-safety device manufacturer offering an alternative pathway to reducing needlestick injuries in hospital blood draw workflows. Competes for the same hospital safety-budget dollars as PIVO, although via a different architectural approach.

TypeEmerging player
Description

Family-owned manufacturer of blood collection systems and pre-analytical products serving hospitals and reference labs. Sarstedt competes in the same blood draw workflow that PIVO enables and is often evaluated alongside PIVO for inpatient specimen quality initiatives.

TypeBroad incumbent
Description

Major medical product distributor and manufacturer of clinical and surgical supplies including vascular access offerings. Cardinal Health competes at the distribution and contract level for hospital blood collection and vascular access spend.

TypeEmerging player
Description

Manufacturer of blood collection tubes and pre-analytical products. While not a direct IV catheter competitor, Greiner overlaps with PIVO's downstream workflow of high-quality blood specimen handling and competes for share of hospital phlebotomy supply budgets.

TypeBroad incumbent
Description

Acquirer of Velano Vascular and now the global marketer of the PIVO platform. BD's Medication Delivery Solutions and Vascular Access Management portfolio includes Nexiva, MaxZero, and Vacutainer products that overlap directly with Velano's pre-acquisition offerings and compete with the same hospital customers.

TypeDirect peer
Description

Vascular access and infusion therapy manufacturer with the Arrow peripheral IV catheter line and needle-safety products. Teleflex targets the same hospital vascular access teams and competes for similar value-analysis committee approvals.

TypeDirect peer
Description

European-headquartered single-use medical devices company with a strong peripheral IV catheter and neonatal/pediatric vascular access portfolio. Vygon competes for hospital vascular access contracts on similar clinical and cost-reduction grounds as Velano/BD's PIVO.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Velano Vascular

Vascular Access / Needle-Free Blood Collection Medical Devicesvelanovascular.com

Velano Vascular developed the PIVO™ needle-free blood collection platform, which advances a flexible tube through existing peripheral IV catheters to enable inpatient blood draws without additional venipuncture. The San Francisco-based medical device company, founded in 2012 and acquired by BD, served hospital systems and integrated delivery networks.

What Velano Vascular does

Velano Vascular is a San Francisco-based medical device company founded in 2012 that developed the PIVO™ needle-free blood collection platform, a proprietary technology that advances a flexible internal flow tube through existing peripheral IV catheters (PIVCs) to enable high-quality blood draws without additional venipuncture. The technology targets the inpatient hospital setting, where the standard of care requires repeated needle sticks for diagnostic blood collection, and addresses pain, vessel damage, preanalytical specimen errors, and needlestick injury exposure. Velano's commercial portfolio, now sold by Becton, Dickinson and Company following an acquisition, includes the PIVO™ Pro Needle-Free Blood Collection Device (20G and 22G-compatible SKUs), the Nexiva™ Closed IV Catheter System with NearPort™ IV Access, and the ExT™ Stabilized Extension Set, sold together as the BD Peripheral Line Draw Solution.

The company monetized through unit-priced hardware sales to hospital systems and integrated delivery networks via direct enterprise sales, GPO contracting, and value analysis committee engagement. Pricing was negotiated at the system level and not publicly disclosed. Velano accumulated approximately $71.2M in disclosed equity funding across eight rounds from 2013 through 2019, with strategic participation from hospital systems including Intermountain Healthcare, Sutter Health, Griffin Hospital, and The Children's Hospital of Philadelphia. The company built an extensive clinical evidence base, including multi-center studies across 23 hospitals demonstrating 56% reduction in preanalytical errors and 19% reduction in IV replacement rates, a 7,600-draw retrospective review showing 39% lower hemolysis versus venipuncture, and infection-prevention evidence documenting 31.9%-41.8% reduction in hospital-onset bacteremia and fungemia rates.

Post-acquisition by BD, PIVO is sold as part of BD's broader vascular access and medication delivery portfolio through BD's global direct sales force, GPO contracts, customer portals, and the BD Learning Academy training platform. Velano Vascular itself no longer operates as an independent entity; its technology, SKUs, clinical evidence, and customer relationships have been absorbed into BD's enterprise.

Velano Vascular firmographics

Firmographics
Name
Velano Vascular
Website
https://velanovascular.com
Company type
Private
Founded year
2012
Operating status
Acquired
Headcount range
11–50 employees
Short description
Velano Vascular developed the PIVO™ needle-free blood collection platform, which advances a flexible tube through existing peripheral IV catheters to enable inpatient blood draws without additional venipuncture. The San Francisco-based medical device company, founded in 2012 and acquired by BD, served hospital systems and integrated delivery networks.
Ownership category
akta.pro rank

Velano Vascular industry classification

Industry
Product category
Vascular Access / Needle-Free Blood Collection Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAKAE
Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories)
SECONDARYHLAHAIAD
Needle-Free Injection Systems (Jet Injectors/Microneedle Patches)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)

Keywords

  • Needle-free blood collection
  • Vascular access devices
  • Peripheral IV catheters
  • Medical device innovation
  • Blood draw technology

Where Velano Vascular is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Velano Vascular business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device Sales — PIVO™ Pro and Compatible IV Catheter Systems: Sale of PIVO™ Pro Needle-Free Blood Collection Devices, Nexiva™ Closed IV Catheter Systems, and ExT™ Stabilized Extension Sets to hospital systems and healthcare providers. Revenue is generated through direct hospital procurement and distribution channels, with devices ordered via standard hospital supply chain and GPO contracting processes. Pricing is typically negotiated at system level through value analysis committees.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPIVO™ Pro Needle-Free Blood Collection Device — 20G compatible
Unit PricingPay-as-you-goPIVO™ Pro Needle-Free Blood Collection Device — 22G compatible
Unit PricingPay-as-you-goNexiva™ Closed IV Catheter System with NearPort™ IV Access — multiple gauge/length configurations
Unit PricingPay-as-you-goExT™ Stabilized Extension Set with NearPort™ IV Access — with and without MaxZero™ Connector

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Velano Vascular product offering

Product offering

Core offering

Velano Vascular developed the PIVO needle-free blood collection platform, a proprietary medical device system that enables high-quality blood draws from existing peripheral IV catheters without additional venipuncture. The portfolio includes the PIVO Pro Needle-Free Blood Collection Device (20G and 22G configurations), the Nexiva Closed IV Catheter System with NearPort IV Access, and ExT Stabilized Extension Sets with optional MaxZero needle-free connectors, sold as the BD Peripheral Line Draw Solution to hospital systems.

Product overview

Velano Vascular (now part of BD) offers the PIVO™ Pro Needle-Free Blood Collection Device, a medical device that enables needle-free blood draws from existing peripheral IV catheters. The product portfolio includes PIVO™ Pro devices in multiple gauge sizes (20G, 22G) and complementary products including the Nexiva™ Closed IV Catheter System with NearPort™ IV Access and ExT™ Stabilized Extension Sets. These products work together as the BD Peripheral Line Draw Solution, designed to reduce needlesticks, improve patient experience, decrease preanalytical errors, and minimize IV catheter replacements. The solution integrates with BD's broader portfolio of blood collection products including BD Vacutainer® Luer-Lok™ Access Device and BD Vacutainer® Blood Collection Tubes.

Differentiator

Problem solved

Functional benefit

Products and services

  • PIVO Pro Needle-Free Blood Collection Device (20G compatible) A needle-free blood collection device compatible with 20G IVs that advances a flexible internal flow tube through existing peripheral IV catheters to access optimal draw conditions beyond the catheter tip, enabling high-quality blood draws without additional venipuncture. Targeted at hospital systems, vascular access teams, and phlebotomy services.
  • PIVO Pro Needle-Free Blood Collection Device (22G compatible) A needle-free blood collection device compatible with 22G IVs or larger, designed to achieve high-quality blood draws from existing peripheral IV catheter lines without additional venipuncture. Targeted at hospital inpatient settings and patients requiring frequent blood sampling.
  • Nexiva Closed IV Catheter System with NearPort IV Access A closed IV catheter system with NearPort IV Access designed to improve peripheral IV catheter dwell times and reduce complications, compatible with the PIVO Pro needle-free blood collection device for integrated vascular access workflows. Targeted at hospital systems and vascular access teams.
  • ExT Stabilized Extension Set with NearPort IV Access (without MaxZero Connector) A stabilized extension set with NearPort IV Access enabling the PIVO Pro needle-free blood collection device to be used with traditional short peripheral IV catheters in hospital workflows. Targeted at hospitals using non-integrated catheter systems that want to adopt needle-free blood collection.
  • ExT Stabilized Extension Set with NearPort IV Access and MaxZero Needle-free Connector A stabilized extension set with NearPort IV Access and an integrated MaxZero needle-free connector providing a closed-system blood draw workflow with PIVO Pro compatibility for traditional short IV catheters. Targeted at hospitals seeking enhanced safety and closed-system compatibility for needle-free blood collection.

Quantifiable outcome

  • 56% decrease in pre-analytical errors
  • +9 more outcomes

Companies that use Velano Vascular

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Velano Vascular technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Velano Vascular partnerships and signals

Strategic signal

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Velano Vascular competitors and assessment

Company assessment

Direct peers

  • ICU Medical: Direct competitor in IV catheters, needle-free connectors, and closed vascular access systems. ICU Medical's acquisition of Smiths Medical expanded its peripheral IV catheter and blood sampling portfolio, putting it in direct competition with the PIVO/Nexiva platform for hospital value-analysis wins.
  • B. Braun Medical: Global manufacturer of IV catheters, needle-free connectors, and infusion therapy disposables. B. Braun competes directly with PIVO/Nexiva for inpatient vascular access standardizations and blood draw workflow improvements in hospital systems.
  • Teleflex: Vascular access and infusion therapy manufacturer with the Arrow peripheral IV catheter line and needle-safety products. Teleflex targets the same hospital vascular access teams and competes for similar value-analysis committee approvals.
  • Vygon: European-headquartered single-use medical devices company with a strong peripheral IV catheter and neonatal/pediatric vascular access portfolio. Vygon competes for hospital vascular access contracts on similar clinical and cost-reduction grounds as Velano/BD's PIVO.

Broad incumbents

  • Medline Industries: Large private manufacturer and distributor of medical supplies with an IV therapy and vascular access portfolio. Medline competes for GPO/IDN vascular access and phlebotomy contracts at hospitals considering PIVO adoption.
  • Cardinal Health: Major medical product distributor and manufacturer of clinical and surgical supplies including vascular access offerings. Cardinal Health competes at the distribution and contract level for hospital blood collection and vascular access spend.
  • Becton, Dickinson and Company (BD): Acquirer of Velano Vascular and now the global marketer of the PIVO platform. BD's Medication Delivery Solutions and Vascular Access Management portfolio includes Nexiva, MaxZero, and Vacutainer products that overlap directly with Velano's pre-acquisition offerings and compete with the same hospital customers.

Emerging players

  • Retractable Technologies: Specialty needle-safety device manufacturer offering an alternative pathway to reducing needlestick injuries in hospital blood draw workflows. Competes for the same hospital safety-budget dollars as PIVO, although via a different architectural approach.
  • Sarstedt: Family-owned manufacturer of blood collection systems and pre-analytical products serving hospitals and reference labs. Sarstedt competes in the same blood draw workflow that PIVO enables and is often evaluated alongside PIVO for inpatient specimen quality initiatives.
  • Greiner Bio-One: Manufacturer of blood collection tubes and pre-analytical products. While not a direct IV catheter competitor, Greiner overlaps with PIVO's downstream workflow of high-quality blood specimen handling and competes for share of hospital phlebotomy supply budgets.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Velano Vascular social profiles

Digital presence

Velano Vascular financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Velano Vascular leadership team

Management profile

Number of profiles

Profiles5 records

Velano Vascular funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Velano Vascular M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Velano Vascular

What does Velano Vascular do?

Velano Vascular developed the PIVO needle-free blood collection platform, a proprietary medical device system that enables high-quality blood draws from existing peripheral IV catheters without additional venipuncture. The portfolio includes the PIVO Pro Needle-Free Blood Collection Device (20G and 22G configurations), the Nexiva Closed IV Catheter System with NearPort IV Access, and ExT Stabilized Extension Sets with optional MaxZero needle-free connectors, sold as the BD Peripheral Line Draw Solution to hospital systems.

Is Velano Vascular a public or private company?

Velano Vascular is a private company. It is classified as corporate owned and is currently acquired.

When was Velano Vascular founded?

Velano Vascular was founded in 2012. It employs 11 to 50 people.

Where is Velano Vascular based?

Velano Vascular is headquartered in San Francisco, United States, in the North America region.

How does Velano Vascular make money?

One revenue line is on record: medical Device Sales — PIVO™ Pro and Compatible IV Catheter Systems.

Who are Velano Vascular's main competitors?

Direct peers on record are ICU Medical, B. Braun Medical, Teleflex and Vygon. Broad incumbents are Medline Industries, Cardinal Health and Becton, Dickinson and Company (BD). Emerging players are Retractable Technologies, Sarstedt and Greiner Bio-One.

Does Velano Vascular have an API?

No public API is recorded for Velano Vascular.

What industry is Velano Vascular in?

Velano Vascular's product category is Vascular Access / Needle-Free Blood Collection Medical Devices. Its primary akta.pro industry code is HLAHAKAE, Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories), with a secondary code of HLAHAIAD, Needle-Free Injection Systems (Jet Injectors/Microneedle Patches). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGlobal Peripheral Intravenous Catheters (PIVCs) Market Research Report 2021The global peripheral intravenous catheters market was valued at USD 3,149.85 million in 2020 and is projected to grow at a CAGR of 1.32% through 2026, driven by increasing hospital admissions linked to aging populations and chronic diseases. The report analyzes market segments, geographic trends, and growth drivers, noting that North America dominates due to its large geriatric population and high ICU admissions. Key trends include rising demand for safety PIVCs with integrated needlestick injury protection and technological advancements in catheter design, while Becton Dickinson and Company recently acquired Velano Vascular to expand its needle-free blood draw technology.NJBIZBD acquisition of Velano Vascular adds needle-free blood draw technologyBD announced on July 20 its acquisition of Velano Vascular, adding needle-free blood draw technology to its portfolio. The FDA-cleared PIVO device allows low-acuity patients to have only one stick for their hospital stay, reducing pain and improving satisfaction. BD expects a multi-year transformation process to make this the global standard of care.GlobeNewswireVelano’s Vascular Access Technologies Help Hospitals Meet 2021 Infusion Therapy Standards of PracticeVelano Vascular announced its needle-free PIVO device is included in the 2021 Infusion Therapy Standards of Practice, citing decreased hemolysis rates. The device is the only FDA-cleared device meeting this standard, and hospitals using it have avoided millions of unnecessary needle sticks since 2019.GlobeNewswireVelano Vascular Named Top Impact Company for 2021 by Real LeadersVelano Vascular was named a Top Impact Company for 2021 by Real Leaders for its needle-free blood draw technology. The company's PIVO device has avoided over a million unnecessary needle sticks since 2019. The company aims to expand One-Stick Hospitalization as difficult venous access cases rise.GlobeNewswireVelano Vascular Makes Streamlined Virtual Training Tools Available to U.S. Hospitals to Aid in the COVID-19 ResponseVelano Vascular made its remote training program for hospitals widely available, initially developed with partners using its PIVO needle-free blood draw device during COVID-19. One Pacific Northwest hospital deployed it to train over 80 registered nurses in five days. The company expanded its PIVO inventory and rolled out the training for hospitals interested in rethinking blood draws.PR NewswireBlood Collection Market Size Worth $13.99 Billion By 2026 | CAGR 6.6%: Grand View Research, Inc.Grand View Research projects the global blood collection market to reach $13.99 billion by 2026, expanding at a CAGR of 6.6%, driven by rising incidence of non-communicable and infectious diseases. The diagnostics application segment and hospitals held the largest market shares in 2018, with North America leading regionally due to advanced healthcare infrastructure. Notable developments include Velano Vascular's $10 million investment from Intermountain Healthcare in August 2019 for its FDA-cleared PIVO needle-free blood collection technology.FinSMEsVelano Vascular Closes Second Tranche of $25M Growth FinancingVelano Vascular closed a second $25M growth financing tranche, bringing total funding to over $50M from insiders, venture capital, hospital partners, and undisclosed healthcare multinationals. The company will use the funds to accelerate commercialization and launch additional inpatient medical device solutions.MedCity NewsVelano Vascular reels in $25M to keep building blood-draw businessVelano Vascular closed $25 million in funding to advance its PIVO device, which draws blood through an existing catheter. The company has raised over $50 million total, and the device has been used in more than 1 million procedures. New products targeting vascular access are planned for 2020.GlobeNewswireVelano Secures Additional Funding to Meet Commercial Demand for PIVO, Fueled by Industry Move to One-Stick HospitalizationVelano Vascular closed a $25 million growth financing, bringing total funding to over $50 million. The capital will fund commercialization of its needle-free PIVO device, which has crossed one million procedures. The company cites rising demand from the One-Stick Hospitalization trend.PR NewswireBlood Collection Market Size, Share & Trends Analysis Report By Product, By Application, By End-Use And Segment Forecasts, 2019 - 2026Reportlinker published a market analysis report projecting the global blood collection market to reach USD 13.99 billion by 2026, growing at a CAGR of 6.6%, driven by rising incidence of non-communicable diseases and trauma injuries. In August 2019, Velano Vascular received a USD 10 million investment from Intermountain Healthcare for its FDA-cleared PIVO needle-free blood collection technology. Key companies profiled in the market include Abbott Laboratories, NIPRO Medical Corp., Becton Dickinson and Company, Terumo Corp., Medtronic, and Qiagen.